CA1332809C - Sustained release pharmaceutical compositions - Google Patents

Sustained release pharmaceutical compositions

Info

Publication number
CA1332809C
CA1332809C CA000548872A CA548872A CA1332809C CA 1332809 C CA1332809 C CA 1332809C CA 000548872 A CA000548872 A CA 000548872A CA 548872 A CA548872 A CA 548872A CA 1332809 C CA1332809 C CA 1332809C
Authority
CA
Canada
Prior art keywords
composition according
hydroxypropyl methylcellulose
acetylsalicylic acid
microcrystalline cellulose
weight ratio
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA000548872A
Other languages
English (en)
French (fr)
Inventor
Henry C. Gan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz Canada Inc
Original Assignee
Sandoz Canada Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Canada Inc filed Critical Sandoz Canada Inc
Application granted granted Critical
Publication of CA1332809C publication Critical patent/CA1332809C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA000548872A 1986-10-09 1987-10-08 Sustained release pharmaceutical compositions Expired - Lifetime CA1332809C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions
GB8624213 1986-10-09

Publications (1)

Publication Number Publication Date
CA1332809C true CA1332809C (en) 1994-11-01

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000548872A Expired - Lifetime CA1332809C (en) 1986-10-09 1987-10-08 Sustained release pharmaceutical compositions

Country Status (24)

Country Link
JP (1) JPS63101334A (hu)
KR (1) KR880004801A (hu)
AU (1) AU7942087A (hu)
BE (1) BE1000732A5 (hu)
CA (1) CA1332809C (hu)
CH (1) CH675831A5 (hu)
DE (1) DE3733540A1 (hu)
DK (1) DK527487A (hu)
ES (1) ES2014518A6 (hu)
FI (1) FI874414A (hu)
FR (1) FR2604902B1 (hu)
GB (2) GB8624213D0 (hu)
GR (1) GR871550B (hu)
HU (1) HU201875B (hu)
IL (1) IL84104A0 (hu)
IT (1) IT1221493B (hu)
LU (1) LU87009A1 (hu)
NL (1) NL8702294A (hu)
NO (1) NO874200L (hu)
NZ (1) NZ222083A (hu)
PH (1) PH24227A (hu)
PT (1) PT85880B (hu)
SE (1) SE8703889L (hu)
ZA (1) ZA877617B (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
KR100660594B1 (ko) * 1999-03-31 2006-12-22 얀센 파마슈티카 엔.브이. 방출 조절형 제제중의 프리젤라틴화 전분
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (sv) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
EP1803447B1 (en) * 2004-09-09 2009-07-22 Psicofarma, S.A. De C.V. Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (fr) * 1972-02-22 1973-08-22 Lilly Co Eli Particules de napsylate de propoxyphene retard et procede de fabrication de ces particules
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (de) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen Oral retardierte acetylsalicylsaeureformulierungen
KR850700212A (ko) * 1984-03-21 1985-12-26 죠지 드모트 서방성 약제학적 캼셀제

Also Published As

Publication number Publication date
HUT52958A (en) 1990-09-28
PT85880B (pt) 1990-07-31
FR2604902B1 (fr) 1991-04-26
FI874414A0 (fi) 1987-10-07
PT85880A (en) 1987-11-01
SE8703889L (sv) 1988-04-10
LU87009A1 (fr) 1988-05-03
ZA877617B (en) 1989-05-30
HU201875B (en) 1991-01-28
GB2195893B (en) 1991-05-08
ES2014518A6 (es) 1990-07-16
DK527487D0 (da) 1987-10-08
PH24227A (en) 1990-05-04
FI874414A (fi) 1988-04-10
GB8723515D0 (en) 1987-11-11
DK527487A (da) 1988-04-10
KR880004801A (ko) 1988-06-27
NL8702294A (nl) 1988-05-02
AU7942087A (en) 1988-04-14
FR2604902A1 (fr) 1988-04-15
GB8624213D0 (en) 1986-11-12
GB2195893A (en) 1988-04-20
NZ222083A (en) 1991-05-28
CH675831A5 (hu) 1990-11-15
IT8748469A0 (it) 1987-10-08
IL84104A0 (en) 1988-03-31
NO874200D0 (no) 1987-10-07
SE8703889D0 (sv) 1987-10-08
DE3733540A1 (de) 1988-04-14
GR871550B (en) 1988-02-15
JPS63101334A (ja) 1988-05-06
BE1000732A5 (fr) 1989-03-21
IT1221493B (it) 1990-07-06
NO874200L (no) 1988-04-11

Similar Documents

Publication Publication Date Title
EP1058538B2 (en) Fast disintegrating tablets
US4842866A (en) Slow release solid preparation
KR101631140B1 (ko) 지속 방출형 경구용 아세트아미노펜/트라마돌 제형
Bredenberg et al. In vitro and in vivo evaluation of a new sublingual tablet system for rapid oromucosal absorption using fentanyl citrate as the active substance
US20210137973A1 (en) Pharmaceutical compositions
US8461210B2 (en) Fast release paracetamol tablets
JPH059413B2 (hu)
AU2002361198B2 (en) 5HT4 partial agonist pharmaceutical compositions
EP1351668A1 (en) Sustained release pharmaceutical dosage forms with minimized ph dependent dissolution profiles
AU2002249881A1 (en) Sustained release pharmaceutical dosage forms with minimized PH dependent dissolution profiles
IL135130A (en) A pharmaceutical preparation containing claudronate as an active ingredient and microcrystalline cellulose that has undergone silification as an excipient
TW508242B (en) Pharmaceutical composition comprising paracetamol
JPH07558B2 (ja) モピダモール製剤
CA2182004C (en) Film coated tablet of paracetamol and domperidone
CA1332809C (en) Sustained release pharmaceutical compositions
HUE030609T2 (hu) Új gyógyászati készítmények álmatlanság kezelésére
EP2983719A1 (en) Manufacturing process for effervescent dosage forms
US4601895A (en) Delayed-action acetylsalicylic acid formulations for oral administration
JPH0757726B2 (ja) 高分子量ヒドロキシプロピルメチルセルロースを基剤にした徐放性錠剤
JPH10279476A (ja) ロキソプロフェンナトリウム含有錠剤
KR101046789B1 (ko) 안정성이 개선된 암로디핀 속붕해성 정제 및 그의 제조방법
JPS59193815A (ja) 錠剤の製法
JP4249847B2 (ja) ビタミンkを含有する口腔内崩壊型錠剤
WO1998042310A2 (en) Fast release compressed tablet of flurbiprofen
JP2000273038A (ja) 口腔内溶解性錠剤

Legal Events

Date Code Title Description
MKEX Expiry